Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: Patterns of recurrence

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 3, 1997, Pages 541-550

  Fisher, Barbara J ^a,d   Perera, Francisco E ^a   Cooke, Andrew L ^b   Opeitum, Abiola ^c   Venkatesan, Varagur ^a   Dar, A Rashid ^a   Stitt, Larry ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Department of Radiation Oncology   (Canada)

^c Centre Regional De Cancerologie De Windsor   (Canada)

^d LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Breast cancer; Chemotherapy; Locoregional recurrence

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 0030788303     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00001-1     Document Type: Article

References (28)

1. Arrigada, R.; Rutqvist, L.; Mattsson, A.; Kramar, A.; Rotstein, S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J. Clin. Oncol. 13:2869-2878; 1995.
2. Axelsson, C.; Blichert-Toft, M. Low-risk breast cancer patients treated by mastectomy and lower axillary dissection: The present status of the Danish Breast Cancer Cooperative Group Trial 77-A. Acta. Oncol. 7:605-609; 1988.
3. Castiglione-Gertsch, M.; Johnsen, C.; Goldhirsch, A., et al. The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 year follow-up. Ann. Oncol. 5:717-724; 1994.
4. Fisher, B.; Wickerham, D.; Deutsch, M.; Anderson, S.; Redwood, C.; Fisher, E. Breast tumor recurrence following lumpectomy with and without breast irradiation: An overview of recent NSABP findings. Semin. Surg. Oncol. 8:153-160; 1992.
5. Fisher, B.; Fisher, E.; Redmond, C. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of I-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J. Clin. Oncol. 4:929-941; 1986.
6. Fisher, E.; Gregorio, R.; Redmond, C.; Kim, W.; Fisher, B. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol #4): III. The significance of extranodal extension of axillary disease. Am. J. Clin. Pathol. 65:439-444; 1976.
7. Fowble, B.; Gray, R.; Gilchrist, K.; Goddman, R. L.; Taylor, S.; Tormey, D. C. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J. Clin. Oncol. 6:1107-1117; 1988.
8. Fowble, B.; Solin, L.; Schultz, D.; Goodman, R. Frequency, sites of relapse and outcome of regional nodal failures following conservative surgery and radiation for early breast cancer. Cancer 72:1247-1260; 1993.
9. Halverson, K.; Taylor, M.; Perca, C.; Garcia, D.; Myerson, R.; Philpott, G.; Levy, J.; Simpson, J.; Tucker, G.; Rish, C. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for Stage I and II breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 26:593-599; 1993.
10. Hartveit, F.; Skjaerven, A.; Mackle, B. Prognosis in breast cancer patients with tumor cells in efferent vessels of their axillary nodes. J. Pathol. 139:379-382; 1983.
11. Leborgne, F.; Leborgne, J.; Ortega, B.; Doldan, R.; Zubizarreta, E. Breast conservation treatment of early stage breast cancer: Patterns of failure. Int. J. Radiat. Oncol. Biol. Phys. 31:765-775; 1995.
12. Klefstrom, P.; Grohn, P.; Heinonen, E.; Holsti, L.; Holsti, P. Adjuvant postoperative radiotherapy, chemotherapy and immunotherapy in stage III breast cancer. II. % year results and influence of levamisole. Cancer 60:936-942; 1987.
13. Levine, M. N.; Bramwell, V.; Abu-Zahra, H.; Goodyear, M. D.; Arnold, A.; Findlay, B.; Skillings, J.; Gent, M. The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation. Br. J. Cancer 65(1):130-132; 1992.
14. Levine, M.; Gent, M.; Hymiuh, W.; Bramwell, V.; AbuZahra, H.; DePouw, S.; Arnold, A.; Findlay, B. ; Levin, L.; Skillings, J.; Bush, H.; Goodyear, M.; Roberts, R. A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer. J. Clin. Oncol. 87:1217; 1990.
15. Marks, L. B.; Halperin, E. C.; Prosnitz, L. R.; Ross, M.; Vredenburgh, J. J.; Rosner, G. L.; Peter, W., and the Cancer and Leukemia Group B. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than 10 positive axillary lymph nodes. Int. J. Radiat. Oncol. Biol. Phys. 23:1021-1026; 1992.
16. Morrison, J.; Kelly, K.; Howell, A., et al. West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer. J. Natl. Cancer Inst. Monogr. 11:85-88; 1992.
17. Morrison, J.; Kelly, K.; Howell, A., et al. West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: Results after a median follow-up of 7 years. I. Patients with involved axillary nodes. Br. J. Cancer 60:911-918; 1989.
18. Overgaard, M.; Christen, J. J.; Johansen, H., et al. Evaluation of radiotherapy in high risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG) Trial. Int. J. Radiat. Oncol. Biol. Phys. 19:1121-1124; 1990.
19. Pierce, L.; Oberman, H.; Strawderman, M.; Lichter, A. Microscopic extracapsular extension in the axilla: Is this an indication for axillary radiotherapy? Int. J. Radiat. Oncol. Biol. Phys. 33:253-259; 1995.
20. Pisonsky, T.; Ingle, J.; Schaid, D.; Haas, A.; Krook, J.; Donohue, J.; Witzig, T. L.; Wold, L. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node positive breast cancer. Cancer 72:1247-1260; 1993.
21. Ragaz, J.; Jackson, S. M.; Plenderleith, I. H.; Wilson, K.; Basco, V.; Knowling, M.; Worth, A.; Spinelli, J.; Ng, V. Can adjuvant radiotherapy improve the overall survival of breast cancer patients in the presence of adjuvant chemotherapy? Ten year analysis of the British Columbia Randomized Trial. Abst. 40. Proc. Am. Soc. Clin. Oncol.; 1992.
22. Richards, M.; O'Reilly, S.; Howell, A., et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: An update of the Guy's/Manchester trial. J. Clin. Oncol. 8:2032-2039; 1990.
23. Rose, M.; Henderson, C.; Gelman, R.; Boyages, J.; Gore, S.; Come, S.; Silver, B.; Recht, A.; Connolly, J.; Schnitt, S.; Coleman, C.; Harris, J. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int. J. Radiat. Oncol. Biol. Phys. 17:711-717; 1989.
24. Rubens, R.; Hayward, J.; Knight, R., et al. Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet 1:839-843; 1983.
25. Senn, H.; Barett-Mahler, A.; Jungi, W. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results. Eur. J. Cancer 25:513-525; 1992.
26. Stefanik, D.; Goldberg, R.; Byrne, P.; Smith, F.; Ueno, W.; Smith, L.; Harter, K.; Bachenheimer, L.; Beiser, C.; Dritschilo, A. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 3:5:660-665; 1985.
27. Sykes, H.; Sim, D.; Wong, C.; Cassady, J.; Salmon, S. Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: Evaluation of the role of postoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 16:641-647; 1989.
28. Wilking, N.; Rutquist, E.; Cartensen, H. J.; Mattson, A.; Shoog, L. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol. 31:1:29-35; 1992.